Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
BMC Cancer|May 7, 2022
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 12, 2020
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)Kazumi Nishino, Yutaka Fujiwara, Yuichiro Ohe, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 25, 2025
A Randomized Open-Label, Noninferiority, Phase 3, Multicenter, Controlled Trial to Compare Laparoscopic Surgery With Open Surgery for Symptomatic, Noncurable Stage IV Colorectal Cancer (JCOG1107)Tomonori Akagi, Masafumi Inomata, Ryo Kanzaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 2005
Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese populationSatoru Koyano, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2020
[A Case of Esophagogastric Junction(EGJ)Cancer for Which Pathological Complete Response(pCR)Was Obtained by Multidisciplinary Treatment]Hirofumi Sugita, Shinichi Sakuramoto, Junya Aoyama, et al.
Drug Metabolism and Pharmacokinetics|January 16, 2007
Fourteen novel genetic variations and haplotype structures of the TYMS gene encoding human thymidylate synthase (TS)Su-Ryang Kim, Shogo Ozawa, Yoshiro Saito, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2014
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapyTsuyoshi Shirakawa, Ken Kato, Kengo Nagashima, et al.
Cancer Chemotherapy and Pharmacology|July 21, 2016
A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumabNaoki Takahashi, Satoru Iwasa, Masaru Fukahori, et al.
Anticancer Research|July 3, 2017
Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative IntentYoshitaka Honma, Nobukazu Hokamura, Kengo Nagashima, et al.
International Journal of Clinical Oncology|June 20, 2026
Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overviewAyumu Matsuoka, Fumio Nagashima, Asao Ogawa, et al.
Pageof 22